Grantham, Mayo, Van Otterloo & Co (GMO)’s Grupo Cibest SA CIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2M Buy
250,323
+15,106
+6% +$1.11M 0.05% 195
2025
Q4
$15M Buy
235,217
+21,500
+10% +$1.29M 0.04% 209
2025
Q3
$11.1M Buy
213,717
+149,212
+231% +$7.2M 0.03% 227
2025
Q2
$2.98M Sell
64,505
-47,700
-43% -$1.98M 0.01% 346
2025
Q1
$4.51M Sell
112,205
-69,600
-38% -$2.73M 0.01% 310
2024
Q4
$5.73M Sell
181,805
-92,500
-34% -$2.98M 0.02% 292
2024
Q3
$8.61M Sell
274,305
-98,323
-26% -$3.22M 0.03% 285
2024
Q2
$12.2M Sell
372,628
-155,083
-29% -$5.32M 0.04% 255
2024
Q1
$18.1M Buy
527,711
+239,896
+83% +$7.78M 0.07% 200
2023
Q4
$8.86M Buy
287,815
+65,593
+30% +$1.78M 0.04% 247
2023
Q3
$5.93M Buy
222,222
+181,615
+447% +$5.05M 0.03% 309
2023
Q2
$1.08M Buy
40,607
+23,907
+143% +$624K 0.01% 484
2023
Q1
$420K Buy
16,700
+5,500
+49% +$149K ﹤0.01% 580
2022
Q4
$320K Hold
11,200
﹤0.01% 625
2022
Q3
$273K Sell
11,200
-1,200
-10% -$34.6K ﹤0.01% 643
2022
Q2
$382K Buy
12,400
+3,000
+32% +$118K ﹤0.01% 639
2022
Q1
$401K Buy
+9,400
New +$339K ﹤0.01% 621
2021
Q2
Sell
-20,300
Closed -$649K 732
2021
Q1
$649K Buy
20,300
+2,700
+15% +$95.9K ﹤0.01% 659
2020
Q4
$707K Buy
+17,600
New +$549K ﹤0.01% 630
2019
Q3
Sell
-4,200
Closed -$214K 735
2019
Q2
$214K Sell
4,200
-124,100
-97% -$6.2M ﹤0.01% 677
2019
Q1
$6.55M Sell
128,300
-120,100
-48% -$5.59M 0.05% 229
2018
Q4
$9.46M Buy
+248,400
New +$9.92M 0.08% 144
2018
Q2
Sell
-105,700
Closed -$4.44M 564
2018
Q1
$4.44M Sell
105,700
-239,500
-69% -$10.4M 0.03% 240
2017
Q4
$13.7M Buy
345,200
+137,200
+66% +$5.55M 0.08% 140
2017
Q3
$9.52M Buy
+208,000
New +$9.37M 0.06% 178
2016
Q4
Sell
-5,300
Closed -$207K 511
2016
Q3
$207K Sell
5,300
-3,900
-42% -$145K ﹤0.01% 472
2016
Q2
$321K Buy
+9,200
New +$326K ﹤0.01% 511

Other funds holding CIB

Grantham, Mayo, Van Otterloo & Co (GMO)'s CIB Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Grupo Cibest SA (CIB) stake by 6.4% in Q1 2026, buying an estimated $1.11M and bringing the position to 250,323 shares worth $18.2M. The position accounts for 0.05% of the portfolio, ranked #195.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CIB in Q2 2016 and has held it in 27 quarters since. 201 funds tracked by Wall St. Rank hold CIB as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 250,323 shares of Grupo Cibest SA worth $18.2M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 15,106 Grupo Cibest SA shares in Q1 2026, an estimated $1.11M.
  • Grupo Cibest SA made up 0.05% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #195 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Grupo Cibest SA in Q2 2016 and has held it in 27 quarters since.
  • 201 funds tracked by Wall St. Rank held Grupo Cibest SA as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.